Dudediligence.

BeOne Medicines AG

ONCNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$1.00BSep ’24$1.13BDec ’24$1.12BMar ’25$1.32BJun ’25$1.41BSep ’25$1.50BDec ’25$1.51BMar ’26$1.71BJun ’26
Net income, by quarter
−$121.3MSep ’24−$151.9MDec ’24$1.3MMar ’25$94.3MJun ’25$124.8MSep ’25$66.5MDec ’25$227.4MMar ’26$237.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$1.18B$1.42B$2.46B$3.81B$5.34B
Gross profit$1.01B$1.13B$2.08B$3.22B$4.67B
Operating income−$1.44B−$1.79B−$1.21B−$568.2M$447.1M
Net income−$1.46B−$2.00B−$881.7M−$644.8M$286.9M
Operating cash flow−$1.30B−$1.50B−$1.16B−$140.6M$1.13B
Free cash flow−$1.56B−$1.82B−$1.72B−$633.3M$941.7M
Cash$4.38B$3.87B$3.17B$2.63B$4.55B
Debt$2.93B$2.48B$6.29B$1.02B$1.02B
Shares outstanding1.33B1.36B1.36B1.39B1.44B